Geode Capital Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
FLAM
O
DCM
VCM
AC
Geode Capital Management's NPCE Position: Q1 2026 in Review
Geode Capital Management increased its Neuropace (NPCE) stake by 3.7% in Q1 2026, buying an estimated $328K and bringing the position to 618,119 shares worth $8.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2488.
Geode Capital Management first reported a position in NPCE in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.21M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.
- Geode Capital Management held 618,119 shares of Neuropace worth $8.13M as of Q1 2026.
- Geode Capital Management bought 21,871 Neuropace shares in Q1 2026, an estimated $328K.
- Neuropace made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2488 holding.
- Geode Capital Management first reported a position in Neuropace in Q2 2021 and has held it in 20 quarters since.
- Geode Capital Management's Neuropace position peaked at $9.21M in Q4 2025.
- 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.